Exoxemis Inc

For 20 years, Exoxemis, Inc has been the leader in the development of broad-spectrum haloperoxidase-based products for use in high-value product areas, including a biological entity for use in high morbidity/mortality applications. We are committed to integrating our technology with the intellectual, financial, and commercial strengths of prospective partners to develop innovative products and long-term relationships.